Enterprise solution

Shaping the future of stroke care

Philips is committed to strengthening stroke care, helping to build a system that better serves patients across their entire care experience. This includes not only developing the right solutions, but also driving advocacy for better access to stroke care globally.
Shaping the future of stroke care to improve the lives of millions
Acute ischemic stroke is the second leading cause of mortality and a key cause of long-term disability worldwide1. Philips is a technology leader committed to strengthening stroke care, helping to build a system that better serves patients across their entire care experience. This includes not only developing the right solutions but also driving advocacy for better access to stroke care globally. Together, we can expand access and create a better care pathway that speeds up diagnostic decisions, improving stroke care and patient outcomes to make a difference for stroke patients worldwide.
Leading experts in field of stroke about Improving stroke care

Driving improved access to stroke care around the world

  • Endovascular stroke treatment revolutionized stroke management in 2015, changing the outlook for stroke patients with its ability to save millions from life-long disability
  • Philips offers solutions to transform stroke care, but currently <5% of stroke patients receive adequate treatment2
  • Improving access to care requires global investments in healthcare infrastructure and the specialist workforce
  • Philips seeks to lead stroke care change, working with organizations to inform and educate government and policymakers on the potential impact of stroke care investment

Innovations that make a difference in the stroke care pathway

  • Tempus ALS monitor to quickly share data with the hospital and alert personnel during EMS transport
  • Telestroke program for access to stroke specialists to enhance diagnosis and potentially increase tPA administration during the time-sensitive acute stroke phase
  • Advanced imaging of Spectral CT 7500 and SmartSpeed MR, and the alerts of Nicolab StrokeViewer3* help speed time to treatment
  • Azurion Image Guided Therapy drives fast, decisive treatment of stroke patients day and night
  • ePatch** to help prevent secondary stroke by proactive, early detection of Afib

Speed is key in delivering time-sensitive, life-saving care in stroke

  • Philips CT and MR systems offer fast exams with exceptional image quality for diagnostic confidence
  • In stroke, time is brain and Azurion neuro suite features a 12% reduction in in-lab preparation time supported by ProcedureCards4
  • Integration of Nicolab StrokeViewer into workflows reduces the number of undetected large vessel occlusions (LVOs) by 20%5 and door-to-groin puncture time by 17%6
  • ePatch wearable Holter device delivers continuous, high-quality ECG data for 24 hours and up to 14 days

Why a better care pathway for stroke is essential and what Philips is doing to help

  • Every 2 seconds someone in the world is affected by stroke7, 40% of stroke patients arrive too late for basic stroke treatment8 and <5% of stroke patients receive adequate treatment2
  • Complexity adds time to stroke patient management and a network of separate, yet highly interdependent, workflows must work fluidly together
  • Gaps in information, communication and access to expertise can cause delays, with tragic consequences for stroke patients
  • Philips is committed to strengthening the stroke care system, helping to build a system that better serves patients across the care journey

  1. 23%

    increase in diagnostic confidence

    23%

    increase in diagnostic confidence

    Save time by creating neurology scans that visualize vitally important characteristics. Decide based on images with enhanced grey/white matter differentiation and reduction in beam-hardening artifacts. Philips Spectral CT 7500 increases diagnostic confidence due to improved lesion conspicuity.9

    Read more

  2. 20%

    reduction in initially undetected LVOs5

    20%

    reduction in initially undetected LVOs5

    Interact with StrokeViewer from Azurion at tableside without breaking sterility to streamline stroke workflows. Use of StrokeViewer reduces initially undetected LVOs by 20%5, which potentially increases the number of patients treated with endovascular thrombectomy (EVT).

    Download

  3. 16

    minutes door-to-groin time with Direct to Angio Suite (DTAS)

    16

    minutes door-to-groin time with Direct to Angio Suite (DTAS)

    We are investigating if more eligible acute stroke patients can be treated by bringing them directly to the angio suite for diagnosis and treatment. A single-center study showed door-to-groin time reduced from 70 to 16 minutes (conventional workflow vs DTAS), with better 90-day outcomes10.

    Read more

  4. 63%

    reduction in patient transfers to the ICU4

    63%

    reduction in patient transfers to the ICU4

    Since implementing Philips’ patient monitoring technology in 2015, Saratoga Hospital has reduced patient transfers to the intensive care unit (ICU) by 63 percent and eliminated patient codes within its 20-bed orthopedic unit, which dropped from three or four codes per year to zero.

    Read more
Philips supports collaborative stroke care
See how Philips can help you save critical time to help improve stroke patient outcomes, from emergency care to fast diagnosis and confident treatment to post-stroke patient care.
Reduce uncertainty at first contactSupport faster diagnosisImage Guided Therapy Azurion neuro suiteDirect to Angio SuiteEarly detection of Afib

Portfolio highlights

  • Radiologist sitting behind the MRI console looking at clinical images acquired with Compressed SENSE thumbnail

    MR SmartSpeed fast imaging technology

    AI-based MRI acceleration software that increases speed and image quality to enhance productivity and boost diagnostic confidence.

  • neurovascular care thumbnail

    Neurovascular suite

    Enhance neurovascular care with Philips' Neuro suite: quality imaging, efficient workflows and precise tools for stroke and AVM treatments.

1/3
Portrait of Mayank
portrait of personPortrait of Carla
Frequently asked questions

Documentation

Joint WSO-Philips policy paper
PDF|(3.05 MB)
Footnotes
  1. www.who.int/data/gho/data/themes/mortality-and-global-health-estimates
  2. Saini V, et al. Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology. 2021;97:S6-S16
  3. StrokeViewer is a trademark of Nicolab.
  4. The results achieved in this first Azurion lab performance study (2017) have been verified by an independent third party. Results are specific to the institution where they were obtained (St. Antonius hospital, Nieuwegein, The Netherlands) and may not reflect the results achievable at other institutions.
  5. Fasen, et al. Neuroradiology. 2022.
  6. Multicenter Innovate study across a leading Hub and Spoke network in The Netherlands in 2020, data collection ongoing. Streamlined stroke workflow | StrokeViewer | Nicolab
  7. Lindsay P, et al. World Stroke Organization global stroke services guidelines and action plan. Int J Stroke. 2014 Oct;9 Suppl A100:4-13
  8. Saver JL, et al. The “golden hour” and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset. Stroke. 2010 Jul;41(7):1431-9.
  9. Analysis by SNUH - Results from case studies are not predictive of results in other cases. Results in other cases may vary.
  10. www.ahajournals.org/doi/10.1161/STROKEAHA.118.021989
  11. Requena M, Vanden Bavière H, Verma S, et al. Cost-utility of direct transfer to angiography suite (DTAS) bypassing conventional imaging for patients with acute ischemic stroke in Spain: results from the ANGIOCAT trial. Journal of NeuroInterventional Surgery Published Online First: 27 April 2023. doi: 10.1136/jnis-2023-020275
Disclaimer
*This solution is not available in all countries. Consult your local Philips representative for more detailed information.
**Philips ePatch® is a Class IIa medical device and validated as an Ambulatory ECG device (Holter) using the Harmonized Standard ISO60601-2-47 and developed using EN13485 as a quality management system.